Database searching
The search yielded 157 studies (MEDLINE n = 77, PsycINFO/PsycArticles n = 65, Japan Medical Abstracts Society n = 13, Other methods n = 2). After removing duplicate studies (n = 31), we included 126 studies in the first screening. Subsequently, 122 were excluded and four studies proceeded to full-text screening. The kappa score for the first screening was 0.66. Two studies that did not meet the article type criteria were excluded (not using quantitative scales to measure outcomes (25), n = 1; not peer-reviewed original articles (28), n = 1). Finally, two studies were included in this systematic review (29, 30). The study selection flowchart is presented in Fig. 1.
Study description
The included studies are summarized in Table 1. One study was conducted in the Netherlands (NLD) and Belgium (BE) in 2021 (29), and the other in the UK (United Kingdom) in 2022 (30). The NLD and BE study was a cohort study (29), and The UK study was a pre-post study without a control group and included a mixed-method approach (30).
There were 239 participants in the NLD and BE study (29, 30), and 47 in the UK study (29, 30). Participants self-reported post-COVID-19 symptoms in both studies (29, 30). The participants were largely middle-aged women or female (the NLD and BE study: median 50.0 age years [interquartile range 39.0–56.0], women 82.8%, the UK study: mean 48.8 age years [Standard Deviation (SD) 11.0], female 83.0%) (29, 30). Sixty two (26.0%) and two (4.3%) participants were hospitalized in the NLD and BE and UK studies, respectively, and only the NLD and BE study provided information about admission to the Intensive Care Unit (ICU). None of the participants was admitted to the ICU (29). In the NLD and BE study, participants’ had experienced COVID-19-related symptoms for six months; in the UK study, participants had experienced PASC for an average of 377.3 days (SD = 171.8).
The exposure of the NLD and BE study was registration in a Facebook group of peers or online COVID-19 panels (29). The intervention in the UK study was 8 weeks of peer support combined with workshops for self-management of physical and mental health, facilitated by trained medical experts using positive psychology approaches for self-management. Patients and healthcare professionals developed content using co-design methods. The interventions included content and self-management techniques. Optionally, weekly online interactions with peers through virtual communication (Zoom), discussion forums, and email were provided (30).
The outcomes in the NLD and BE study were work productivity and activity impairment (absenteeism, presenteeism, work productivity, and activity impairment), functional status, and QOL, using the Work Productivity, Activity Impairment Questionnaire and the 5-level EuroQol-5 Dimensions version (EQ-5D-5L) (29). In the UK study, the outcomes were positive mental well-being, self-efficacy for managing conditions, and loneliness using the (short form) Warwick-Edinburgh Mental Well-being Scale (SWEMWBS and WEMWBS), the 6-item Self-Efficacy for Managing Chronic Disease Scale (SEMCD6), and The University of California, Los Angeles (UCLA) Loneliness Scale, Version 3 (30). Both studies used validated scales. The follow-up periods were between 3 and 6 months after the onset of COVID-19-related symptoms in the NLD and BE study (29) and at the end of the 8-week intervention in the UK study (30). Only short form of Positive Mental Well-being scores were measured across the program at three time points (week 1, 4, and 7) in the UK study (30).
Results of individual studies
The NLD and BE study showed a statistically significant improvement between the time points in all outcomes (absenteeism: p < 0.001; presenteeism: p < 0.001, work productivity: p < 0.001, activity impairment: p < 0.001, functional status: p < 0.001, EQ-5D [index: p < 0.001, index < percentile five values: p < 0.001, Today’s health status: p < 0.001]) (29). The UK study showed a statistically significant improvement, except for loneliness (WEMWBS: p < 0.001, Cohen’s d = 0.8; SEMCD6: p = 0.01, Cohen’s d = 0.5; Loneliness p = 0.60, Cohen’s d = 0.1; and SWEMWBS: p < 0.001). The SWEMWBS scores increased between weeks 1 and 4 (p < 0.001) and between weeks 1 and 7 (p = 0.001); however, scores between weeks 4 and 7 did not differ (p = 0.25) (30).
<Table 1. Characteristics of included studies>
Risk of bias assessment
The risk of bias assessment result is shown in Table 2. The NLD and BE study recruited participants consecutively (29) and data were collected prospectively. Therefore, we rated them low for the selection of participants. Neither study had control and self-reported participation in the exposure or intervention (29, 30). Both studies measured the outcomes using self-report questionnaires (29, 30). Therefore, we rated the confounding variables, exposure measurements, and blinding of outcome assessments as high. Details of the rationale for the risk of bias assessment for each study are provided in Appendix 2.
<Table 2. Result of risk of bias assessment>
Results of individual exposure or intervention
Table 3 presents the form, approach, and content of each exposure or intervention. Both studies provided group peer support (29, 30). The NLD and BE study contained no detailed explanation of exposure in the article (29); we retrieved the contents from the explanation of the Facebook group or panel. According to this description, a group or panel provides a place to share experiences and information about post-COVID-19 symptoms (31, 32). The panel included a medical professional as a board member (33). The UK study provided an intervention combining peer support and online workshop content. Each content involved self-management tools for weekly goal setting, exercises, and activities (30). The NLD and BE study did not report the frequency of participation in online peer support groups (29); the UK study described the frequency of sessions but not the frequency of participation (30).
<Table 3. Details of exposure or intervention>